Kyndryl Holdings Inc vs GeneDx Holdings Corp — how do they compare? Kyndryl Holdings Inc trades at $13.26 (market cap $2.91B), while GeneDx Holdings Corp trades at $82 (market cap $2.44B). The key difference: Kyndryl Holdings Inc is the larger of the two by market cap, and GeneDx Holdings Corp is trading nearer its 52-week high, Kyndryl Holdings Inc nearer its low. Which is the better fit depends on your goals.
| KD | WGS | |
|---|---|---|
Market Cap | $2.91B | $2.44B |
Sector | Technology | Technology |
52-Week High | $33.14 | $167.51 |
52-Week Low | $10.59 | $34.51 |
Enterprise Value | $5.74B | $2.48B |
Trailing returns across standard periods
Latest headlines on both assets
Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives.
Read more on KD →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →